John M. Kane, MD

John Kane, MD, considers prevention and treatment approaches for mood disorders.

Delays in treatment for psychosis can be associated with poorer outcomes.

Therapeutic drug monitoring is vastly underused in psychiatry but could better inform clinical decision-making.

Although clozapine is often ignored by many clinicians, the antipsychotic should be considered for more patients.

Telepsychiatry training for residents will ensure that the potential of the technology is fully realized.

Long-acting injectable antipsychotics have potential to improve patient adherence, reduce relapse risk.